Medicine Man Technologies, Inc. (SHWZ)

OTCMKTS · Delayed Price · Currency is USD

0.000001

0.00 (0.00%)

At close: Jul 23, 2026

Medicine Man Technologies Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	174.91	172.45	159.38	108.42	24	10.62
Revenue Growth	5.55%	8.20%	47.00%	351.74%	126.03%	34.00%
Gross Profit	68.01	76.02	80.29	49.35	6.77	3
Operating Income	-10.97	5.09	20.87	10.41	-22.9	-13.61
Net Income	-67.86	-42.7	-26.27	7.17	-19.42	-16.98
Earnings Per Share	-0.91	-0.66	-0.49	-0.06	-0.47	-0.50
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Retail	158.29	155.46	141.25	73.76	3.86	-
Wholesale	16.32	16.77	17.82	34.43	18.65	7.82
Other	0.29	0.22	0.3	0.23	1.49	-
Total	174.91	172.45	159.38	108.42	24	12.4

Cash & Debt

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Investments	12.39	19.71	39.4	106.89	1.51	12.26
Total Debt	198.19	191.87	148.23	106.33	21.55	0.07
Net Cash (Debt)	-185.8	-172.16	-108.82	0.56	-20.04	12.19
Net Cash Growth	-	-	-	-	-	383.66%
Net Cash Per Share	-2.50	-2.67	-2.03	0.01	-0.49	0.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Cash Flow	6.59	12.2	6.69	8.4	-9.8	-7.55
Capital Expenditures	-5.31	-7.87	-14.01	-5.64	-0.77	-0.2
Free Cash Flow	1.28	4.34	-7.31	2.76	-10.57	-7.75
Free Cash Flow Growth	-87.92%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Gross Margin	38.88%	44.09%	50.38%	45.52%	28.23%	28.27%
Operating Margin	-6.27%	2.95%	13.09%	9.60%	-95.43%	-128.22%
Pretax Margin	-23.83%	-8.59%	-2.24%	17.45%	-84.65%	-165.36%
Profit Margin	-38.80%	-24.76%	-16.48%	6.62%	-80.90%	-159.87%
FCF Margin	0.73%	2.51%	-4.59%	2.54%	-44.03%	-73.02%

Valuation

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug '26 Aug 11, 2026	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
PE Ratio	-	-	-	11.11	-	-
Forward PE	-	82.40	17.92	4.20	-	-
P/FCF Ratio	0.00	10.07	-	28.89	-	-
PS Ratio	0	0.25	0.49	0.74	2.60	10.08